Pioneer Research is developing cutting-edge, targeted treatment using microProteins for clinical use. Founded in 2021, Pioneer Research is using its microProtein platform to identify and develop clinical therapeutics where current therapy is lacking or severely compromised. The companies unique approach provides the next generation biopharmaceutical approach to diseases where current treatment regimes are insufficient and with a significant medical need.
Pioneer Research is established in 2021 and work targeted towards its first product candidates for clinical trials.